Sharper Focus Emerging in $1.5 Billion California Plan to Delve into Neuro Diseases Such as Brain Cancer and Autism
Patients and biotech firms not at key meetings
California’s stem cell agency is veering towards a tighter focus in its drive to beef up the impact of spending $1.5 billion or even more on neuro diseases such as stroke and dementia.
That conclusion emerged from a meeting Wednesday of the neuro task force of the California Institute for Regenerative Medicine (CIRM). The directors’ task force’s efforts…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.